Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer.

Roth C, Rack B, Müller V, Janni W, Pantel K, Schwarzenbach H. · 2010

Read Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. by Roth C, Rack B, Müller V, Janni W, Pantel K, Schwarzenbach H. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3046429.txt.

Description

Roth and coauthors tested in 2010 whether tiny regulatory RNAs floating in blood could flag breast cancer and its spread. These molecules, called microRNAs in full, help control gene activity and leak from tumors into the bloodstream. Blood was drawn from women with early breast cancer, women whose cancer had spread, and healthy women, and four cancer linked microRNAs were measured.

Total blood RNA and one microRNA separated early patients from healthy women clearly. Three microRNAs separated the spread group from healthy controls. Within patients, higher levels of several markers tracked with the presence of distant spread and with larger, later stage tumors. The authors call this a pilot study, the first of its kind for these markers. They propose blood microRNAs as a low burden way to detect progression that deserves larger trials.

Catalog record

CREATORRoth C, Rack B, Müller V, Janni W, Pantel K, Schwarzenbach H.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3046429

Browse the full library · About the Tower of Babel